Elevated interleukin-8 levels in the urine of children with renal scarring and/or vesicoureteral reflux. 1996

M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
Department of Urology, Fukuoka City Medical Center for Sick Children and Infectious Diseases, Kyushu University, Japan.

OBJECTIVE Elevation of urinary levels of interleukin-6 and 8 has been observed in patients with acute urinary tract infections. However, to our knowledge there have been no studies concerning the secretion of interleukin-6 and 8 into the urine after acute inflammation has resolved and renal scarring has occurred. On the other hand, it is well known that cytokines are variously related to glomerular diseases and, thus, it is possible that the progression of reflux nephropathy depends on interleukin-6 or 8. Therefore, we assessed urinary levels of interleukin-6 and 8 in children with vesicoureteral reflux and/or renal scarring. METHODS We evaluated interleukin-6 and interleukin-8 levels in the urine of 32 children without a urinary tract infection who presented or were admitted to our hospital because of vesicoureteral reflux between April and December 1994. Interleukin-6 and 8 were determined using a commercially available human enzyme-linked immunosorbent assay kit and the 2-step sandwich method. RESULTS Urinary interleukin-6 levels were below the lower detection limit (less than 10 pg./ml.) in all samples. There were statistically significant differences between urinary interleukin-8 levels in children with and without renal scarring (p = 0.001), and with and without vesicoureteral reflux (p = 0.0246). CONCLUSIONS Urinary interleukin-8 is an effective marker for renal scarring and vesicoureteral reflux.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002921 Cicatrix The fibrous tissue that replaces normal tissue during the process of WOUND HEALING. Scars,Cicatrization,Scar,Scarring
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D014718 Vesico-Ureteral Reflux Retrograde flow of urine from the URINARY BLADDER into the URETER. This is often due to incompetence of the vesicoureteral valve. Primary Vesicoureteral Reflux,Secondary Vesicoureteral Reflux,Vesicoureteral Reflux Grade1,Vesicoureteral Reflux1,Vesicoureteral Reflux,Vesicoureteral Reflux 1,Grade1, Vesicoureteral Reflux,Reflux, Primary Vesicoureteral,Reflux, Secondary Vesicoureteral,Reflux, Vesico-Ureteral,Reflux, Vesicoureteral,Reflux1, Vesicoureteral,Vesico Ureteral Reflux,Vesicoureteral Reflux, Primary,Vesicoureteral Reflux, Secondary,Vesicoureteral Reflux1s
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
September 2012, Pediatric nephrology (Berlin, Germany),
M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
August 1990, The Journal of urology,
M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
June 1975, The Journal of pediatrics,
M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
January 2007, Srpski arhiv za celokupno lekarstvo,
M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
November 1989, AJR. American journal of roentgenology,
M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
December 2022, Pediatric clinics of North America,
M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
February 2023, Journal of pediatric urology,
M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
May 2010, Pediatric nephrology (Berlin, Germany),
M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
December 2008, Nature clinical practice. Urology,
M Haraoka, and K Senoh, and N Ogata, and M Furukawa, and T Matsumoto, and J Kumazawa
August 2007, Pediatric nephrology (Berlin, Germany),
Copied contents to your clipboard!